Hereditary Renal Cancer Syndromes: Clinicopathologic Features and Correlation With Tumors Harboring Somatic Mutations

Area of Science:

• Oncology
• Genetics
• Nephrology

Background:

• Hereditary renal cancer syndromes account for 5-8% of renal cell carcinomas (RCCs).
• These syndromes stem from germline alterations, primarily in tumor suppressor genes.
• Molecular testing advances have revealed new hereditary syndromes and the genetic basis of kidney tumors.

Purpose of the Study:

• To review established and novel hereditary renal cancer syndromes.
• To detail their clinical, pathological, and molecular characteristics.
• To emphasize genotype-phenotype correlations and germline-somatic alteration relationships.

Main Methods:

• Literature review of hereditary renal cancer syndromes.
• Analysis of clinical, pathological, and molecular data.
• Focus on genotype-phenotype correlations and genetic alterations.

Main Results:

• Summary of well-established and newly identified hereditary renal cancer syndromes.
• Highlighting of key clinical, pathological, and molecular features.
• Discussion of genotype-phenotype correlations and germline-somatic alterations.

Conclusions:

• Understanding hereditary renal cancer syndromes is crucial for diagnosis and risk assessment.
• Genotype-phenotype correlations guide surveillance and management strategies.
• Early detection through clinical suspicion optimizes patient outcomes.